LCLNP Trademark

Trademark Overview


On Monday, July 18, 2022, a trademark application was filed for LCLNP with the United States Patent and Trademark Office. The USPTO has given the LCLNP trademark a serial number of 79352347. The federal status of this trademark filing is REGISTERED as of Tuesday, May 28, 2024. This trademark is owned by NanoVation Therapeutics Inc.. The LCLNP trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Lipid-based pharmaceuticals, namely, lipid-based drug delivery vehicle preparations in the form of lipid formulations that facilitate the delivery of pharmaceuticals for the diagnosis, treatment or prevention of diseases and disorders, namely, cancer, infectious diseases, genetic disorders, inflammation and immunological disorders, and for reducing symptoms associated with aging; nucleic acid-based pharmaceuticals, namely, DNA- and RNA-based pharmaceuticals for the diagnosis, treatment or prevention of diseases and disorders, namely, cancers, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging; small molecule pharmaceuticals for use in the diagnosis, treatment or prevention of cancer, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging; protein- and peptide-based pharmaceuticals for use in the diagnosis, treatment or prevention of can...

Pharmaceutical research and development services; pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals; pharmaceutical formulation development services
lclnp

General Information


Serial Number79352347
Word MarkLCLNP
Filing DateMonday, July 18, 2022
Status700 - REGISTERED
Status DateTuesday, May 28, 2024
Registration Number7393905
Registration DateTuesday, May 28, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2024

Trademark Statements


Goods and ServicesLipid-based pharmaceuticals, namely, lipid-based drug delivery vehicle preparations in the form of lipid formulations that facilitate the delivery of pharmaceuticals for the diagnosis, treatment or prevention of diseases and disorders, namely, cancer, infectious diseases, genetic disorders, inflammation and immunological disorders, and for reducing symptoms associated with aging; nucleic acid-based pharmaceuticals, namely, DNA- and RNA-based pharmaceuticals for the diagnosis, treatment or prevention of diseases and disorders, namely, cancers, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging; small molecule pharmaceuticals for use in the diagnosis, treatment or prevention of cancer, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging; protein- and peptide-based pharmaceuticals for use in the diagnosis, treatment or prevention of cancer, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging
Goods and ServicesPharmaceutical research and development services; pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals; pharmaceutical formulation development services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 14, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 14, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNanoVation Therapeutics Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCA

Party NameNanoVation Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCA

Party NameNanoVation Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCA

Trademark Events


Event DateEvent Description
Thursday, October 13, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, October 14, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 18, 2022APPLICATION FILING RECEIPT MAILED
Saturday, March 11, 2023NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, May 2, 2023ASSIGNED TO EXAMINER
Friday, June 2, 2023NON-FINAL ACTION WRITTEN
Saturday, June 3, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, July 11, 2023REFUSAL PROCESSED BY MPU
Tuesday, July 11, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, August 1, 2023REFUSAL PROCESSED BY IB
Monday, January 8, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 8, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 9, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 7, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, February 7, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, February 7, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, February 7, 2024EXAMINER'S AMENDMENT ENTERED
Thursday, February 8, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 21, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 21, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 21, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Monday, March 11, 2024NOTIFICATION PROCESSED BY IB
Tuesday, March 12, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, March 13, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 13, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, May 28, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, May 28, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Monday, April 1, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB